NCT03174561

Inuline Supplement in Patients With Irritable Bowel Syndrome

Status unknown NA Last updated 2 June 2017

What this trial tests

NA trial testing Inuline, Choline and Silymarin in Irritable Bowel Syndrome in 50 participants. Status unknown.

Timeline

1 May 2017

Primary endpoint
28 February 2018

30 April 2018

Quick facts

Lead sponsor	SC Fiterman Pharma SRL
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 May 2017
Primary completion	28 February 2018
Estimated completion	30 April 2018
Sites	1 location across Romania

Drugs / interventions tested

• Inuline, Choline and Silymarin
• diet restriction

Conditions studied

• Irritable Bowel Syndrome — all drugs for Irritable Bowel Syndrome →

Sponsor

SC Fiterman Pharma SRL

Who can join

Adults 18 to 75, any sex, with Irritable Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study investigate the efficacy of the combination inuline, choline and silymarin in alleviating the symptomatology of the patients with irritable bowel syndrome with constipation in a randomized, cross-over, no treatment controlled study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with Constipation-Randomized Case-Control Study.
   Bărboi OB, Chirilă I, Ciortescu I, Anton C, et al · · 2022 · cited 9× · PMID 35456341 · DOI 10.3390/jcm11082248